Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Sala

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Heliyon|April 15, 2024
Economic assessment of NGS testing workflow for NSCLC in a healthcare settingDavide Seminati, Vincenzo L'Imperio, Gabriele Casati, et al.
Journal for Immunotherapy of Cancer|September 1, 2025
Regulatory polymorphisms of <i>MSH6</i>, <i>MSH2</i>, <i>FBXO11,</i> and <i>PPP1R21</i> genes affect survival of patients with immunotherapy-treated lung cancerMartina Esposito, Sara Noci, Francesca Minnai, et al.
Nature Communications|August 30, 2025
Non-invasive action potential recordings using printed electrolyte-gated polymer field-effect transistorsAdrica Kyndiah, Giulia Zoe Zemignani, Carlotta Ronchi, et al.
Stem Cell Reports|November 11, 2020
Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced ArrhythmiasKarina O Brandão, Lettine van den Brink, Duncan C Miller, et al.
Nature Communications|May 6, 2026
An organic artificial cardiomyocyteDace Gao, Junpeng Ji, Simone De Prà, et al.
Cardiovascular Research|February 4, 2017
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytesMarcella Rocchetti, Luca Sala, Lisa Dreizehnter, et al.
Circulation|June 28, 2024
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and PatientsLia Crotti, Raquel Neves, Federica Dagradi, et al.
Clinical Lung Cancer|June 28, 2020
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective StudyAndrea Luciani, Antonio Marra, Luca Toschi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 10, 2022
Continuous Bayesian variant interpretation accounts for incomplete penetrance among Mendelian cardiac channelopathiesMatthew J O'Neill, Luca Sala, Isabelle Denjoy, et al.
Light, Science & Applications|December 31, 2024
Membrane-targeted push-pull azobenzenes for the optical modulation of membrane potentialValentina Sesti, Arianna Magni, Matteo Moschetta, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Heliyon|April 15, 2024
Economic assessment of NGS testing workflow for NSCLC in a healthcare settingDavide Seminati, Vincenzo L'Imperio, Gabriele Casati, et al.
Journal for Immunotherapy of Cancer|September 1, 2025
Regulatory polymorphisms of <i>MSH6</i>, <i>MSH2</i>, <i>FBXO11,</i> and <i>PPP1R21</i> genes affect survival of patients with immunotherapy-treated lung cancerMartina Esposito, Sara Noci, Francesca Minnai, et al.
Nature Communications|August 30, 2025
Non-invasive action potential recordings using printed electrolyte-gated polymer field-effect transistorsAdrica Kyndiah, Giulia Zoe Zemignani, Carlotta Ronchi, et al.
Stem Cell Reports|November 11, 2020
Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced ArrhythmiasKarina O Brandão, Lettine van den Brink, Duncan C Miller, et al.
Nature Communications|May 6, 2026
An organic artificial cardiomyocyteDace Gao, Junpeng Ji, Simone De Prà, et al.
Cardiovascular Research|February 4, 2017
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytesMarcella Rocchetti, Luca Sala, Lisa Dreizehnter, et al.
Circulation|June 28, 2024
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and PatientsLia Crotti, Raquel Neves, Federica Dagradi, et al.
Clinical Lung Cancer|June 28, 2020
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective StudyAndrea Luciani, Antonio Marra, Luca Toschi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 10, 2022
Continuous Bayesian variant interpretation accounts for incomplete penetrance among Mendelian cardiac channelopathiesMatthew J O'Neill, Luca Sala, Isabelle Denjoy, et al.
Light, Science & Applications|December 31, 2024
Membrane-targeted push-pull azobenzenes for the optical modulation of membrane potentialValentina Sesti, Arianna Magni, Matteo Moschetta, et al.
Pageof 9